SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-053734
Filing Date
2020-11-13
Accepted
2020-11-13 08:15:33
Documents
3
Period of Report
2020-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ktra-8k_20201113.htm 8-K 35683
2 EX-99.1 ktra-ex991_6.htm EX-99.1 72149
3 GRAPHIC gq5fgu25awp2000001.jpg GRAPHIC 115441
  Complete submission text file 0001564590-20-053734.txt   268212
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 201309228
SIC: 2834 Pharmaceutical Preparations